Trace elements in human physiology and pathology: Zinc and metallothioneins

Biomedicine and Pharmacotherapy

Volumn 57, Issue 9, 2003, Pages 399-411

  Tapiero, Haim ^a   Tew, Kenneth D ^b  

^a UNIV PARIS SUD   (France)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Deficiency; Homeostasis; Human; Metallothioneins; Zinc

Indexed keywords

3 PHOSPHOSHIKIMATE 1 CARBOXYVINYLTRANSFERASE; 4 AMINOBUTYRIC ACID RECEPTOR; AMINO ACID DERIVATIVE; DIHYDROOROTASE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROLASE; HYDROLASE LIGASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYASE; MESSENGER RNA; METALLOTHIONEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NUCLEIC ACID; OXIDOREDUCTASE; PEPTIDE; PHOSPHOLIPASE C; PROTEIN DERIVATIVE; PROTEIN FARNESYLTRANSFERASE; SUPEROXIDE DISMUTASE; SYNTHETASE; TRACE ELEMENT; TUBULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC ION;

ACTION POTENTIAL; APOPTOSIS; BRAIN FUNCTION; CATALYSIS; CELL FUNCTION; CELL MEMBRANE; CELL ORGANELLE; CELL SECRETION; CHELATION; CHROMATIN; CROSS LINKING; CYTOPLASM; DIFFUSION; DRUG MECHANISM; ENZYME ACTIVITY; ESOPHAGITIS; GENE EXPRESSION; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYDROPHILICITY; ION CURRENT; ION TRANSPORT; METAL BINDING; MOLECULAR DYNAMICS; NEUROTRANSMISSION; NONHUMAN; NUTRITIONAL STATUS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TISSUE DISTRIBUTION; ZINC DEFICIENCY; ZINC FINGER MOTIF;

EID: 0345096663     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00081-7     Document Type: Review

References (209)

1. Paulsen I.T., Saier M.H. Jr. A novel family of ubiquitous heavy metal ion transport proteins. J Membr Biol. 156:1997;99-103.
2. Palmiter R.D., Findley S.D. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14:1995;639-649.
3. McMahon R.J., Cousins R.J. Regulation of the zinc transporter ZnT-1 by dietary zinc. Proc Natl Acad Sci USA. 95:1998;4841-4846.
4. Palmiter R., Cole T., Quaife C., Findley S. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci USA. 93:1996;14934-149349.
5. Fleming M.D., Romano M.A., Su M.A., et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA. 95:1998;1148-1153.
6. Gunshin H., Mackenzie B., Berger U.V., et al. Cloning and characterization of mammalian proton-coupled metal ion transporter. Nature (Lond). 388:1997;482-488.
7. Berg J.M., Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science. 271:1996;1081-1085.
8. King J.C., Shames D.M., Woodhouse L.R. Zinc homeostasis in humans. J Nutr. 130:2000;1360S-1366S.
9. Cousins R.J. Zinc. Ziegler E.E., Filer L.J. Jr. Present knowledge in nutrition. 1996;293-306 DC: ILSI Press, Washington.
10. Van Wouwe J.P., Uijlenbroek J.J.M. The role of the pancreas in the regulation of zinc status. Biol Trace Elem Res. 42:1994;143-149.
11. De Lisle R.C., Sarras M.P. Jr, Hidalgo J., Andrews G.K. Metallothioneins a component of exocrine pancreas secretion: implications for zinc homeostasis. Am J Physiol. 271:1996;C1103-C1110.
12. Oberlas D. Mechanism of zinc homeostasis. J Inorg Biochem. 62:1996;231-241.
13. Johnson P.E., Hunt C.D., Milne D.B., Mullen L.K. Homeostatic control of zinc metabolism in men: zinc excretion and balance in men fed diets low in zinc. Am J Clin Nutr. 57:1993;557-565.
14. Fung E.B., Ritchie L.D., Woodhouse L.R., Roehl R., King J.C. Zinc absorption in women during pregnancy and lactation: a longitudinal study. Am J Clin Nutr. 66:1997;80-88.
15. King J.C., Shames D.M., Lowe N.M., Woodhouse L.R., et al. Effect of acute zinc depletion on zinc homeostasis and plasma zinc kinetics in men. Am J Clin Res. 74:2001;116-124.
16. Forbes R.M., Erdman J.W. Bioavailability of trace mineral elements. Annu Rev Nutr. 3:1983;213-231.
17. Lönnerdal B. Intestinal absorption of zinc. Mills C.F. Zinc in Human Biology. 1989;33-55 Springer-Verlag, London.
18. Hempe J.M., Cousins R.J. Cysteine-rich intestinal protein and intestinal metallothioneins: an inverse relationship as a conceptual model for zinc absorption in rats. J Nutr. 122:1992;89-95.
19. Jackson M.J. Physiology of zinc: general aspects. Mills C.F. Zincin human biology. 1989;1-14 Springer Verlag, London.
20. Dore-Duffy P., Peterson M., Catalanotto F., et al. Zinc profiles in rheumatoid arthritis. Clin Exp Rheumatol. 8:1990;541-546.
21. Cousins R.J. Systemic transport of zinc. Mills C.F. Zinc in human biology. 1989;79-83 Springer Verlag, London.
22. De Kok J., Van Der Schoot, et al. The uptake of zinc by erythrocytes under near-physical conditions. Biol Trace Elem Res. 38:1993;13-26.
23. Tibaduiza E.C., Bobilya D.J. Zinc transport across and endothelium includes vesicular cotransport with albumin. J Cell Physiol. 167:1996;539-547.
24. Gachot B., Tauc M., Morat L., Poujeol P. Zinc uptake by proximal cells isolated from rabbit kidney: effect of cysteine and histidine. Pflügers Arch Physiol. 419:1991;583-587.
25. Kirchgessner M., Weigand E. Zinc absorption and excretion in relation to nutrition. Metal Ions Biol Syst. 15:1983;319-361.
26. Hempe J.M., Cousins R.J. Cysteine-rich intestinal protein binds zinc during transmucosal zinc transport. Proc Natl Acad Sci USA. 88:1991;9671-9674.
27. Palmiter R.D., Cole T.B., Findley S.D. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J. 15:1996;1784-1791.
28. Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physisol Rev. 73:1993;79-118.
29. Prasad A.S., Miale A. Jr, Farid Z., Sandstead H.H., Schubert A.R., Darby W.J. Biochemical studies on dwarfism, hypogonadism and anemia. Arch Int M. 111:1963;407-428.
30. Halstead J.A., Ronaghy H.A., Abadi P., et al. Zinc deficiency in man. The Shiraz experiment. Am J M. 53:1972;277-284.
31. Sandstead H.H. Zinc deficiency. A public health problem? Am J Dis Child. 145:1991;853-859.
32. Moser-Veillon P.B. Zinc: Consumption patterns and dietary recommendations. J Am Diet Assoc. 90:1990;1089-1093.
33. Calhoun N.R., Smith J.C., Becker K.L. The role of zinc in bone metabolism. Orthopedics. 103:1974;212-234.
34. Yamaguchi M., Mochizuki A., Okada S. Stimulation of bone resorption by comparatively high dose of zinc in rats. J Pharm Dyn. 5:1982;501-504.
35. Prasad A.S. Zinc in human health: an update. J Trace Elem Exp M. 11:1998;63-87.
36. Cousins R.J., Leinart A.S. Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin-1. FASEB J. 2:1988;2884-2890.
37. Cui L., Takagi Y., Wasa M., et al. Induction of nitric oxide synthase in rat intestine by interleukin-1 my explain diarrhea associated with zinc deficiency. J Nutr. 127:1997;1729-1736.
38. Driscoll E.R., Bettger W.J. The effect of dietary zinc deficiency in the rat on the lipid composition of the erythrocyte membrane Triton shell. Lipids. 27:1993;972-977.
39. Avery R.A., Bettger W.J. Zinc deficiency alters the protein composition of the membrane skeleton but not the extractability of oligomeric form of spectrin in rat erythrocyte membrane. J Nutr. 122:1992;428-434.
40. Johanning G.L., Browning J.D., Bobilya D.J., et al. Effect of zinc deficiency on enzyme activities in rat and pig erythrocyte membranes. Proc Soc Exp Biol M. 195:1990;224-229.
41. Ruz M., Cavan K.B., Bettger W.J., Gibson R.S. Erythrocyte membranes, neutrophils and platelets as biopsy materials for the assessment of zinc status in humans. Br J Nutr. 68:1992;515-527.
42. Dakshinamurti K., Paulose C., Viswanathan M., Siow Y., Sharma S. Neurobiology of pyridoxine. Ann NY Acad Sci. 585:1990;128-144.
43. Yamada Y., Merrill A.H. Jr, McCormick D.B. Probable reaction mechanisms of flavokinase and FAD synthetase from rat liver. Arch Biochem Biophys. 278:1990;125-130.
44. Jay M., Stuart S.M., McClain C.J., Palmieri D.A., Butterfield D.A. Alterations in lipid membrane fluidity and the physical state of cell surface sialic acid in zinc-deficient rat erythrocyte ghosts. Biochim Biophys Acta. 897:1987;507-511.
45. Keen C.L., Gershwin M.E. Zinc deficiency and immune function. Annu Rev Nutr. 10:1990;415-431.
46. Xie X., Hider R.C., Smart T.G. Modulation of GABA-mediated synaptic transmission by endogenous zinc in the immature rat hippocampus in vitro. J Physiol. 478:1994;75-86.
47. Vinegar B.D., Lansman J.B. Voltage-dependent block by zinc of single calcium channels in mouse myotubes. J Physiol. 425:1990;563-578.
48. Vaillancourt S.J., Allen J.C. Glucocorticoid effects on zinc transport into colostrums and milk of lactating cows. Biol Trace Elem Res. 30:1991;185-196.
49. Klug A., Rhodes D. Zinc fingers: a novel protein motif for nucleic acid recognition. TIBS. 7:1998;464-473.
50. Favier A.E. The role of zinc in reproduction. Hormonal mechanisms. Biol Trace Elem Res. 32:1992;363-382.
51. Neve J. Clinical implications of trace elements in endocrinology. Biol Trace Elem Res. 32:1992;173-185.
52. Pryor W.A. Free radicals. 1966;McGraw-Hill, New York.
53. Bray T.M., Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic Biol M. 8:1990;281-291.
54. Sakanashi T.M., Keen C.L., Hong K.H., Gershwin M.E., Flechter M.P. Zinc deficiency associated alterations in the chemotactic and respiratory burst responses of rat peripheral blood neutrophils. FASEB J. 7:1993;A723. [abstract].
55. Davis C.D., Klevay L.M., Milne D.B., Nielsen F.H. Extracellular superoxide dismutase activity: a promising indicator of zinc status in humans. FASEB J. 12:1998;A346. [abstract].
56. Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplamin. Phys Rev. 65:1985;238-309.
57. Kelly R.E., Mally M.I., Evans D.R. The dihydroorotase domain of the multifunctional protein CAD. J Biol Chem. 261:1986;6073-6083.
58. Washabaugh M.W., Collins K.D. Dihydroorotase from Escherichia coli: sulphydryl group-metal interactions. J Biol Chem. 261:1986;5920-5929.
59. Conte D., Narindrasorasak S., Sarkar B. In vivo and in vitro iron replaced zinc finger generates free radicals and causes DNA damage. J Biol Chem. 271:1996;5125-5130.
60. Hesketh J.E. Zinc binding to tubulin. Int J Biochem. 15:1983;743-746.
61. Wu M.X., Filley S.J., Xiong J., et al. A cysteine in the C-terminal region of alnyl-tRNA synthetase is important for aminoacylation activity. Biochemistry. 33:1994;12260-12266.
62. Padgette S.R., Huynh Q.K., Aykent S., Sammons R.D., et al. Identification of the reactive cysteines of Escherichia coli 5-enolpyruvylshikimate-3-phosphate synthase and their nonessentiality for enzymatic catalysis. J Biol Chem. 263:1988;1798-1802.
63. Tse-Dinh Y.C., Beran-Steed R.K. Escherichia coli DNA topoiisomerease I is a zinc metalloprotein with three repetitive zinc-binding domains. J Biol Chem. 263:1988;15857-15859.
64. Fu H.W., Moomaw J.F., Moomaw C.R., Casey P.J. Identification of cysteine residue essential for activity of protein farnesyltransferase. Cys 299 is exposed only upon removal of zinc from the enzyme. J Biol Chem. 271:1996;28541-28548.
65. Gibbs P.N.B., Gore M.G., Jordan P.M. Investigation of the effect of metal ions on the reactivity of thiol groups in humans: aminolevulinate dehydratase. Biochem J. 225:1985;573-580.
66. Powell S.R. The antioxidant properties of zinc. J Nutr. 130:2000;1447S-1454S.
67. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease: an overview. Packer L., Glazer A.N. Methods in enzymology. 1990;1-85 Academic Press, New York.
68. Chevion M. A site specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic Biol M. 5:1988;27-37.
69. Bhat R., Hadi S.M. DNA breakage by tannic acid and Cu(II): sequence specificity of the reaction and involvement of active oxygen species. Mutat Res Environ Mutagen Rel Subj. 313:1994;39-48.
70. Stadtman E.R. Metal-ion catalysed oxidation of proteins: biochemical mechanism and consequences. Free Radic Biol M. 9:1990;315-325.
71. Har-el R., Chevion M. Zinc(II) protects against metal-mediated free raical induced damage: studies on single and double-strand DNA breakage. Free Rad Res Commun. 12-13:1992;509-516.
72. Bagchi D., Bagchi M., Stohs S.J. Comparative in vitro oxygen radical scavenging ability of zinc methionine and selected zinc salts and antioxidants. Gen Pharmacol. 28:1997;85-91.
73. Lovering K.E., Dean R.T. Restriction of the participation of copper in radical-generating systems by zinc. Free Rad Res Commun. 14:1992;217-225.
74. Afanas Suslova T.B., Cheremisina Z.P., Abramova N.E., Korkina L.G. Study of antioxidant properties of metal aspartates. Analyst. 120:1995;859-862.
75. Shinar E., Rahmilewitz E.A., Shifter A., Rahamim E., Saltman P. Oxidative damage to human red blood cells induced by copper and iron complexes in the presnceof asorbate. Biochim Biophys Acta. 1014:1989;66-72.
76. Reid L.S., Gray H.B., Dalvit C., Wright P.E., Saltman P. Electron transfer from cytochrome b5 to iron and copper complexes. Biochemistry. 26:1987;7102-7107.
77. Persoon-Rothert M., van der Valk-Kokshoom E.J.M., Egas-Kenniphaas J.M., Mauve I., van der Laarse A. Isopoterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation. J Mol Cell Cardiol. 21:1989;1285-1291.
78. Powell S.R. Salicylate trapping of OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart. Free Radic Res Commun. 21:1994;355-370.
79. Powell S.R., Gurzenda E.M., Wingertzohan M.A., Wapnir R.A. Promotion of copper excretion from the isolated perfused rat heart attenuates post ischemic cardiac oxidative injury. Am J Physiol. 277:1999;H956-H962.
80. Willie A.H. Apoptosis: an overview. Br Med Bull. 53:1997;451-465.
81. Webb S., Harrison D., Wyllie A. Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol. 54:1997;1-34.
82. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science (Washington DC). 281:1998;1312-1316.
83. Zalewski P.D., Forbes I.J. Intracellular zinc and the regulation of apoptosis. Watters L.M. Programmed cell death. 1993;73-85 Harwood Publishers, Reading, UK.
84. lo thymocytes by zinc. J Cell Physiol. 164:1995;259-270.
85. Perry D.K., Smyth M.J., Stennicke H.R., Salvesen G.S., Duriez P., Poirier G.G., et al. Zinc a potent inhibitor of the apoptotic protease caspase-3: a novel target for zinc in the inhibition of apoptosis. J Biol Chem. 272:1997;18530-18533.
86. Truong-Tran A.Q., Ho L.H., Chai F., Zalewski P.D. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J Nutr. 130:2000;1459S-1466S.
87. Srinivasula S.M., Fernandes-Alnemri T., Zangrilli J., et al. The ced-3/interleukin 1 converting enzyme-like homolog Mch6and the lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32. J Biol Chem. 271:1996;27099-27106.
88. Takahashi A., Alnemri E.S., Lazebnik Y.A., et al. Cleavage of lamin A by Mch2α but not CPP32: multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA. 93:1996;8395-8400.
89. Aiuchi T., Mihara S., Nakaya M., Masuda Y., Nakajo S., Nakaya K. Zinc ions prevent processing of caspase-3 during apoptosis induced by geranylgeraniol in HL60 cells. J Biochem. 124:1998;300-303.
90. Fukamachi Y., Karasaki Y., Sugiura T., et al. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase in Bcl-2/Bax ratio. Biochem Biophys Res Commun. 246:1998;364-369.
91. Fraker P.J., Osati-Ashtiani F., Wagner B.S., King L.E. Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency. A review. J Am Coll Nutr. 14:1995;11-17.
92. Zalewski P.D., Forbes I.J., Betts W.M. Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin ((2-methyl-8-p- toluenesulphonamido-6-quinolytoxy)acetic acid) new specific fluorescent probe for Zn(II). Biochem J. 296:1993;403-408.
93. Maret W., Vallee B. Thiolate ligands in metallothionein confer redoxactivity of zinc clusters. Proc Natl Acad Sci USA. 95:1998;3478-3482.
94. Wellinghausen N., Rink L. The significance of zinc for leukocyte biology. J Leukoc Biol. 64:1998;571-577.
95. Bettger W.J., O'Dell B.L. Physiological roles of zinc in the plasma membrane of mammalian cells. J Nutr Biochem. 4:1993;194-207.
96. Fraker P.J., King L.E., Laako T., Vollmer T.L. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 130:2000;1399S- 1406S.
97. Fabris N. Immune system and aging: neuroimmunological implications. Int J Immunopathol Pharmacol. 5:1992;93-102.
98. Sunderman F.W. The influence of inc on apoptosis. Ann Clin Lab Sci. 25:1995;134-142.
99. Singh K.P., Zaidi S.I.A., Raiuddin-Saxena A.K., Murthy R.C., Ray P.K. Effect of zinc on immune functions and host resistance against infection and tumor challenge. Immunopharm Immunotox. 14:1992;813-840.
100. Atassi G., Dumont P., Harteel J.C. Potentiation of the anti-tumor activity of 2-formylpyridine thiosemicarbazone by metal chelation: 2-formylpyridine thiosemicarbazone zinc sulphate (NSC 294721). Eur J Cancer. 15:1979;451-459.
101. Jong M.K., Adham N.F., Heng M.C.Y., Costea N.V., Heng M.K. Trace element metabolic alterations of zinc and prostaglandins in both human and animal colonic tumor cells. J Am Coll Nutr. s14:1995;473-479.
102. Chvapil M. Effect of zinc on cells and biomembranes. Med Clin N Am. 60:1976;799-812.
103. Takeyama Y., Ogino K., Segawa H., Kobayashi H., Uda T., Honbara T. Effects of zinc on production of active oxygen species by rat neutrophils. Pharmacol Toxicol. 76:1995;50-55.
104. Baum M., Shor-Posner G., Lu Y. Micronutrients and HIV-disease progression. AIDS. 9:1995;1051-1056.
105. Novick S.G., Godfrey J.C., Godfrey N.J., Wilder H.R. How does zinc modify the common cold? Med Hypoth. 46:1996;295-302.
106. Petrus E.J., Lawson K.A., Bucci L.R., Blum K. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy tested subjects. Curr Ther Res. 59:1998;595-607.
107. ++ inhibits nitric oxide formation in response to polysaccharides: implications in its anti-inflammatory activity. Eur J Pharmacol. 341:1998;265-272.
108. McClain C.J., Hill D.B., Shedlofsky S.I., Gaetke L., Hennig B. Zinc, cytokines and liver disease. Kruse-arres J.D., Schölmerich J. Zinc and diseases of the digestive tract. 1997;77-86 Kluwer Academic Publishers, Dordrecht.
109. Thompson R.P.H. Zinc and immune function in Crohn's disease. Kruse-Jarres J.D., Schölmerich J. Zinc and diseases of the digestive tract. 1997;72-76 Kluwer Academic Publishers, Dordrecht.
110. Scuderi P. Differential effects of copper and zinc on human peripheral blood monocyte cytokine secretion. Cell Immunol. 126:1990;391-405.
111. 2 and histamine levels in the rat gastric glandular mucosa. Digestion. 32:1985;288-295.
112. Wetterholum A., Macchia L., Haeggstrom J.Z. Zinc and other divalent actions inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. Arch Biochem Biophys. 311:1994;263-271.
113. 2. Clin Immunol Immunopathol. 64:1992;184-187.
114. Kiefer L.L., Fieke C.A. Functional characterization of carbonic anhydrase II variants with altered zinc binding sites. Biochemistry. 33:1994;15233-15240.
115. Kruse-Jarres J.D. Basic principles of zinc metabolism. Kruse-Jarres J.D., Schölmerich J. Zinc and diseases of the digestive tract. 1997;3-15 Kluwer Academic Publishers, Dordrecht.
116. Kadakia S.C., Wong R.K.H., Maydonovich C.L., Nelson N.R., Henkin R.I. Serum and tissue zinc concentrations in patients with endoscopic oesophagitis. Dig Dis Sci. 37:1992;513-516.
117. Cho C.H., Fong L.Y.Y., Ma P.C.C., Ogle C.W. Zinc deficiency: its role in gastric secretion and stress-induced gastric ulceration in rats. Pharmacol Biochem Behav. 26:1987;293-297.
118. Glenner G.G., Wong C. Alzheimer disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Comm. 120:1984;885-890.
119. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 82:1985;4245-4249.
120. Chartier-Harlin M.C., Crawford F., Houlden H. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature (Lond). 353:1991;844-846.
121. Younkin S.M., Tanzi R.E., Christen Y. Presenilins and Alzheimer's disease. 1998;Springer Verlag, Heidelberg, Germany.
122. Wyss-Coray T., Masliah E., Mallory M., et al. Amyloidogenesis role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature. 389:1997;603-606.
123. Patterson P., Kordon C., Christen Y. Neuro-immune interactions and neurological and psychiatric disorders. 1999;Springer-Verlag, Heidelberg, Germany.
124. Prelli F., Castano E., Glenner G.G., Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neuro-Chem. 51:1988;648-651.
125. Seubert P., Vigo-Pelfrey C., Esch F.S., et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature (Lond). 359:1992;325-327.
126. Fukahori M., Itoh M. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse. Brain Res. 529:1990;16-22.
127. Mitchell C., Barnes M.I., Grimes L.M. Diethyldithiocarbamate and dithizone augment the toxicity of kainic acid. Brain Res. 506:1990;327-330.
128. Chen N., Moshaver A., Raymond L.A. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol. 51:1997;1015-1023.
129. Paoletti P., Ascher P., Neyton J. High affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci. 17:1997;5711-5725.
130. Traynelis S.F., Burgess M.F., Zheng F., et al. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1-subunit. J Neurosci. 18:1998;6163-6175.
131. A receptor current by zinc and other divalent cations. J Neurosci. 18:1998;2944-2953.
132. Vandenberg R.J., Mitrovic A.D., Johnston G.A.R. Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions. Mol Pharmacol. 54:1998;189-196.
133. Noregaard L., Frederiksen D., Nielsen E.O., Gether U. Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J. 17:1998;4266-4273.
134. Colvin R.A. Characterization of a plasma membrane zinc transporter in rat brain. Neurosci Lett. 247:1998;147-150.
135. Colvin R.A., Davis N., Nipper R.W., Carter P.A. Evidence for a zinc/protonantiporter in rat brain. Neurochem Int. 36:2000;539-547.
136. Koh J.Y., Choi D.W. Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience. 60:1994;1049-1057.
137. Sensi S.L., Canzoniero L.M.T., Yu S.P., et al. Measurement of intracellular free zinc in living cortical neurons: routes of entry. J Neurosci. 17:1997;9554-9564.
138. Erickson J.C., Hollopeter G., Thomas S.A., Froelick G.J., Palmiter R.D. Disruption of metallothionein-III gene in mice: Analysis of brain zinc, behavior, and neuron vulnerability to metals, aging and seizures. J Neurosci. 17:1997;1271-1281.
139. Palmiter R.D. The elusive functions of metallothioneins. Proc Natl Acad Sci USA. 95:1998;8230-8248.
140. Bush A.I., Pettingell W.H. Jr, de Paradis M., Tanzi R.E. Modulation of A beta adhesiveness and secretase site cleavage by zinc. J Biol Chem. 269:1994;12152-12158.
141. Bush A.I., Pettingell W.H. Jr, de Paradis M., Tanzi R.E., Wasco W. The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J Biol Chem. 269:1994;26618-26621.
142. Bush A.I., Pettingell W.H. Jr, Multhaup G., de Paradis M., et al. Rapid induction of Alzheimer A amyloid formation by zinc. Science (Washington DC). 265:1994;1464-1467.
143. Cuajungco M.P., Lee G.J. Zinc and Alzheimer's disease: is there a direct link? Brain Res Rev. 23:1997;219-236.
144. Cornett C.R., Markesbery W.R., Ehmann W.D. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neuro-toxicology. 19:1998;339-345.
145. Danscher G., Jensen K.B., Frederickson C.J., et al. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's disease brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J Neurosci Methods. 76:1997;53-59.
146. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci. 158:1998;47-52.
147. Suh S.W., Jensen K.B., Jensen M.S., et al. Histologic evidence of a zinc role in Alzheimer's disease. Soc Neurosci (Abstr). 24:1998;1217.
148. Corrigan F.M., Reynolds G.M., Ward N.I. Hippocampal tin, aluminium and zinc in Alzheimer's disease. BioMetals. 6:1993;149-154.
149. Constantinidis J. Alzheimer's disease and the zinc theory. Encephale. 16:1990;231-239.
150. Lui E., Fisman M., Wong C., Diaz F. Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, cadmium and metallothionein. J Am Geriatr Soc. 38:1990;633-639.
151. Multhaup G., Masters C.L., Beyreuther K. Oxidative stress in Alzheimer's disease. Alzheimer Rep. 1:1998;147-154.
152. Markesbery W.R. Oxidative stress hypothesis in Alzheimer disease. Free Radic Biol M. 23:1997;134-137.
153. Hensley K., Hall N., Subramaniam R., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem. 65:1995;2146-2156.
154. Smith M.A., Richey Harris P.L., Sayre L., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA. 94:1997;9866-9868.
155. Loeffler D.A., Connor J.R., Juneau P.L., et al. Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. J Neurochem. 65:1995;710-716.
156. Multhaup G., Sclicksupp A., Hess L., et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science. 271:1996;1406-1409.
157. Multhaup G. Amyloid precursor protein, copper and Alzheimer's disease. Biomed Pharmacother. 51:1997;105-111.
158. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci. 143:1996;137-142.
159. Huang X., Atwood C.S., Goldstein L.E., et al. Alzheimer Aβ peptides simultaneously reduce metals and produce reactive oxygen species. Soc Neurosci (Abstr). 23:1997;1663.
160. Bush A.I., Multhaup G., Moir R.D., et al. A novel zinc(II) binding site modulates the function of A4 amyloid protein precursor of Alzheimer's disease. J Biol Chem. 268:1993;16109-16112.
161. Multhaup G., Bush A.I., Pollwein P., Masters C.L. Interaction between the zinc (II) and heparin binding site of the Alzheimer's disease =A4 amyloid precursor protein. FEBS Lett. 355:1994;151-154.
162. Jeandel C., Nicolas M.B., Dubois F., Nabet-Belleville F., Penin F., Cunny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology. 35:1989;275-282.
163. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., Richards R.I. Human metallotionein genes; structure of the functional locus at 16q13. Genomics. 8:1990;513-518.
164. Hamer D.H. Metallothionein. Annu Rev Biochem. 55:1986;913-951.
165. Bryan R.H., Liu J., Choudhuri S., Klaassen C.D. Species variation in hepatic metallothionein. Toxicol Lett. 74:1994;23-33.
166. Bremmer I. Nutritional and physiological significance of metallothionein. Meth Enzymol. 205:1991;25-35.
167. Bremmer I., Beattie J.H. Metallothionein and the trace minerals. Annu Rev Nutr. 10:1990;63-83.
168. Sugiura T., Nakamura H. Metallothionein in platelets. Int Arch Allergy Immunol. 103:1994;341-348.
169. Nartey N.O., Banerjee D., Cherian M.G. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of fetal human liver and kidney and its changes during development. Pathology. 19:1987;233-238.
170. Panemangalore M., Banerjee D., Onosaka S., Cherian M.G. Changes in intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. Dev Biol. 97:1983;95-102.
171. Tsujikawa K., Suzuki N., Sagawa K., et al. Induction and subcellular localization of metallothionein in regenerating rat liver. Eur J Cell Biol. 63:1994;240-246.
172. Cherian M.G. Nuclear and cytoplasmic localization of metallothionein in human liver during development and in tumor cells. Suzuki K.T., Imura N., Kimura M. Metallothionein III. 1993;175-187 Birkhaüser Verlag, Basel.
173. Sato M., Sasaki M., Hojo H. Induction of metallothionein synthesis by oxidative stress and possible role in acute phase response. Suzuki K.T., Imura N., Kimura M. Metallothionein III. 1993;125-140 Birkhaüser Verlag, Basel.
174. Summer K.H., Klein D., De Ruiter N., Abel J. Metallothionein induction by nonsteroidal antiinflammatory drugs. Biol Trace Elem Res. 21:1989;165-169.
175. Anstey A., Marks R., Long C., et al. In vivo photoinduction of metallothionein in human skin by ultraviolet-irradiation. J Pathol. 136:1996;94-100.
176. Vasak M., Kagi J.H.R. Metallothioneins. King R.B. Encyclopedia of inorganic chemistry. vol. 4:1994;2229-2241 Wiley, New York.
177. Jiang L.J., Maret W., Vallee B.L. The glutathione-redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitoldehydrogenase. Proc Natl Acad Sci USA. 95:1998;3483-3488.
178. Kobayashi S., Hirota Y., Sayatosuzuki J., et al. Possible role of metallothionein in the cellular defense-mechanism against UVB-irradiation in neonatal human skin fibroblasts. Photochem Photobiol. 59:1994;650-656.
179. Feldman S.L., Failla M.L., Cousins R.J. Degradation of rat liver metallothioneins in vitro. Biochim Biophys Acta. 544:1978;638-646.
180. Hunziker P.E., Kägi J.H.R. Isolation and characterization of six human hepatic isometallothioneins. Biochem J. 231:1985;375-382.
181. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol. 39:1999;267-294.
182. Kang Y.J. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol M. 222:1999;263-273.
183. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol. 39:1999;267-294.
184. Lazo J.S., Pitt B.R. Metallothionein and cell death by anticancer drugs. Annu Rev Pharmacol Toxicol. 35:1995;635-653.
185. Uchida Y., Takio K., Koiti T., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:1991;337-347.
186. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA. 89:1992;6333-6337.
187. Pountney D.L., Fundel S.M., Faller P., et al. Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain. FEBS Lett. 345:1994;193-197.
188. Kagï J.H.R. Evolution, structure and chemical activity of class I metallothioneins:an overview. Suzuki K.T., Imura N., Kimura M. Metallothionein III. 1993;29-55 Birkhäuser Verlag, Basel.
189. Tsuji S., Kobayashi H., Uchida Y., Ihara Y., Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down regulation in Alzheimer's disease. EMBO J. 11:1992;4843-4850.
190. Cuajungco M.P., Lees G.J. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya. Brain Res. 799:1998;118-129.
191. Kroncke K.-D., Kolb-Bachofen V. Measurement of nitric oxide-mediated effects on zinc homeostasis and zinc finger transcription factors. Meth Enzymol. 301:1999;126-135.
192. Quaife C.J., Findley S.D., Erickson J.C., et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:1994;7250-7259.
193. Schmid C.J., Hamer D.H. Cell specificity and an effect on ras on human metallothionein gene expression. Proc Natl Acad Sci USA. 83:1986;3346-3450.
194. Jahroudi N., Foster R., Price-Haughey J., Beitel G., Gedamu L. Cell-type specific and differential regulation of the human metallothionein genes. J Biol Chem. 265:1990;6506-6511.
195. Samson S.L.-A., Gedamu L. Molecular analyses of metallothionein gene regulation. Prog Nucleic Acid Res Mol Biol. 59:1998;257-288.
196. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol. 59:2000;95-104.
197. Cousins R.J. Metal elements and gene expression. Annu Rev Nutr. 14:1994;449-496.
198. Winge D.R., Dameron C.T. The metallothionein structural motif involved in metalloregulation. Suzuki K.T., Imura N., Kimura M. Metallothionein III. 1993;381-397 Birkhaüser Verlag, Basel.
199. Maret W. Metallothionein disulphide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem Int. 27:1995;111-117.
200. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci USA. 95:1998;3489-3494.
201. Jiang L.J., Maret W., Vallee B.L. The ATP-Metallothionein complex. Proc Natl Acad Sci USA. 95:1998;9146-9149.
202. Ebadi M., Iversen P.L., Hao R., et al. Expression and regulation of brain metallothionein. Neurochem Int. 27:1995;1-22.
203. Masters B.A., Quaife C.J., Erickson J.C., et al. Metallothionein-III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci. 14:1994;5844-5857.
204. Reeves P.G. Adaptation responses in rat to long-term feeding of high zinc diet: emphasis on intestinal metallothionein. J Nutr Biochem. 6:1995;48-54.
205. Moffatt P., Plaa G.L., Denizeau F. Rat hepatocytes with elevated metallothionein expression are resistant to N′-methyl-N′-nitro- nitrosoguanidine cytotoxicity. Toxicol Appl Pharmacol. 136:1996;200-207.
206. Kondo Y., Woo E.S., Michalska A.E., Choo K.H.A., Lazo J.S. Metallothionein null-cells have increased sensitivity to anticancer drugs. Cancer Res. 55:1995;2021-2023.
207. Cai L., Koropatnick J., Cherian M.G. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. Chem Biol Interact. 96:1995;143-155.
208. Lynes M.A., Garvey J.S., Lawrence D.A. Extracellular metallothionein effects on lymphocyte activities. Mol Immunol. 27:1990;211-219.
209. Borghesi L.A., Youn J., Olson E.A., Lynes M.A. Interaction of metallothionein with murine lymphocytes-plasma membrane binding and proliferation. Toxicology. 108:1996;129-140.